Robin Prestwich

12PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersVeterinary epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 22, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.

Sebastian Søby, Robin Prestwich, Niels Gyldenkerne

|Sep 12, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy.

Andrea Kuhnl, S Bouziana, S F Barrington

|Apr 10, 2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.

A Kuhnl, C Roddie, A A Kirkwood

|Oct 14, 2022
Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma.

Zsuzsanna Iyizoba-Ebozue, Sarah Billingsley, Russell Frood

|Apr 06, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.

James M Price, Hitesh B Mistry, Guy Betts

Pageof 2